QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (58) Citing Articles via Google Scholar Google Scholar Articles by Broening, H. W. Articles by Vorhees, C. V. Search for Related Content PubMed PubMed Citation Articles by Broening, H. W. Articles by Vorhees, C. V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 3,4-METHYLENEDIOXYMETHAMPHETAMINE DOPAMINE Medline Plus Health Information Learning Disorders Memory

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 1, 2001, 21(9):3228-3235

3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Learning and Memory Impairments Depend on the Age of Exposure during Early Development

Harry W. Broening, LaRonda L. Morford, Sandra L. Inman-Wood, Masao Fukumura, and Charles V. Vorhees

Division of Developmental Biology, Children's Hospital Research Foundation and University of Cincinnati College of Medicine, Cincinnati, Ohio 45229-3039

Use of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has increased dramatically in recent years, yet little is known about its effects on the developing brain. Neonatal rats were administered MDMA on days 1-10 or 11-20 (analogous to early and late human third trimester brain development). MDMA exposure had no effect on survival but did affect body weight gain during treatment. After treatment, body weight largely recovered to 90-95% of controls. MDMA exposure on days 11-20 resulted in dose-related impairments of sequential learning and spatial learning and memory, whereas neonatal rats exposed on days 1-10 showed almost no effects. At neither stage of exposure did MDMA-treated offspring show effects on swimming ability or cued learning. Brain region-specific dopamine, serotonin, and norepinephrine changes were small and were not correlated to learning changes. These findings suggest that MDMA may pose a previously unrecognized risk to the developing brain by inducing long-term deleterious effects on learning and memory.

Key words: methylenedioxymethamphetamine; development; MDMA; ecstasy; amphetamines; serotonin; dopamine; learning and memory; spatial learning; sequential learning

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/2193228-08$05.00/0

This article has been cited by other articles:

				D. K. Smith, A. B. Johnson, K. C. Pears, P. A. Fisher, and D. S. DeGarmo Child Maltreatment and Foster Care: Unpacking the Effects of Prenatal and Postnatal Parental Substance Use Child Maltreat, May 1, 2007; 12(2): 150 - 160. [Abstract] [PDF]

				N. Easton and C. A. Marsden Ecstasy: Are animal data consistent between species and can they translate to humans? J Psychopharmacol, March 1, 2006; 20(2): 194 - 210. [Abstract] [PDF]

				A. R. Green, A. O. Mechan, J. M. Elliott, E. O'Shea, and M. I. Colado The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") Pharmacol. Rev., September 1, 2003; 55(3): 463 - 508. [Abstract] [Full Text] [PDF]

				L. O'Keefe AAP supports campaign against club drugs AAP News, October 1, 2001; 19(4): 137 - 146. [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help